VCM
HGEN

Valiant Capital Management’s HUMANIGEN, INC. HGEN Stock Holding History

Valiant Capital Management’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,888,607
Closed -$12.2M – 30
2022
Q2 		$12.2M Hold
6,888,607
– – 1.22% 25
2022
Q1 		$20.7M Hold
6,888,607
– – 2.38% 18
2021
Q4 		$25.6M Sell
6,888,607
-185,613
-3% -$1.09M 3.1% 13
2021
Q3 		$42M Hold
7,074,220
– – 3.94% 13
2021
Q2 		$123M Hold
7,074,220
– – 9.23% 3
2021
Q1 		$135M Hold
7,074,220
– – 5.23% 5
2020
Q4 		$124M Hold
7,074,220
– – 5.41% 4
2020
Q3 		$75.3M Buy
+7,074,220
New +$72.6M 3.93% 10

Other funds holding HGEN

GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Valiant Capital Management's HGEN Position: Q3 2022 in Review

Valiant Capital Management sold out of HUMANIGEN, INC. (HGEN) in Q3 2022, closing a stake of 6,888,607 shares — an estimated $12.2M sold.

Valiant Capital Management first reported a position in HGEN in Q3 2020 and held it in 8 quarters. The position peaked at $135M in Q1 2021. 53 funds tracked by Wall St. Rank hold HGEN as of Q3 2022.

  • Valiant Capital Management reported no remaining HUMANIGEN, INC. position as of Q3 2022 after selling out during the quarter.
  • Valiant Capital Management sold 6,888,607 HUMANIGEN, INC. shares in Q3 2022, an estimated $12.2M.
  • Valiant Capital Management first reported a position in HUMANIGEN, INC. in Q3 2020 and held it in 8 quarters.
  • Valiant Capital Management's HUMANIGEN, INC. position peaked at $135M in Q1 2021.
  • 53 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2022.

Based on Valiant Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.